Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition

Wu, L. W., Tao, J. J., McDonnell, D., & Izar, B. (2024). Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition. Melanoma Research, 34(4), 382–385. https://doi.org/10.1097/cmr.0000000000000974
Authors:
Lawrence W Wu
Jacqueline J Tao
Diana McDonnell
Benjamin Izar
Affiliated Authors:
Benjamin Izar
Columbia Affiliation:
Subjects:
Melanoma (MeSH)
Skin Neoplasms (MeSH)
Programmed Cell Death 1 Receptor (MeSH)
Author Keywords:
immunotherapy
nivolumab
pseudoprogression
relatlimab
elink
Publication Type:
Article
Unique ID:
10.1097/cmr.0000000000000974
PMID:
38640504
DOI:
10.1097/cmr.0000000000000974
Journal:
Melanoma Research
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: